Cite
APA Citation
Kayser, S., Feszler, M., Krzykalla, J., Schick, M., Kramer, M., Benner, A., Thol, F., Platzbecker, U., Müller‐Tidow, C., Ho, A. D., Ehninger, G., Heuser, M., Schlenk, R. F., Thiede, C., Röllig, C., & Krämer, A. (2017). clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. European journal of haematology, 99, 544–552. http://access.bl.uk/ark:/81055/vdc_100054240641.0x000047